# Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Study · id `cardio:ct-nct06226805` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06226805](<https://clinicaltrials.gov/study/NCT06226805>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06226805

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 228 participants.

## Technical summary

Registry record NCT06226805. Randomized; quadruple masking; primary purpose prevention. Start 2024-07-31 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 228 participants (planned count; ClinicalTrials.gov record NCT06226805, source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)
- Started: 2024-07-31 (actual) (ClinicalTrials.gov record NCT06226805, source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT06226805, source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)
- Completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT06226805, source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada (ClinicalTrials.gov record NCT06226805, source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06226805-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
- Acronym: RAISE
- Condition: Acute Ischemic Stroke
- Intervention (Drug): BB-031
- Intervention (Drug): Placebo
- Lead sponsor: Basking Biosciences, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 6e6c02dab033f0ad121009a3da26bb478eafc9cca4b894aace1f74ff812de7fa
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
